Answers are grounded in this paper and cite their sources.
This study explored the gut health potential of the green seaweed Ulva rigida (SW-U) and the red seaweed Gracilaria fisheri (SW-G), as well as polysaccharide-enriched extracts (PF-U and PF-G, respectively). The polysaccharide-enriched extracts were not digestible by small intestinal enzymes, but the morphology of samples was changed. After 24 h in vitro fermentation, seaweeds and polysaccharide-enriched extracts significantly increased (p < 0.05) production of total short-chain fatty acids (SCFAs) (29.4–35.4 µmoL/mL) compared to the control (17.9 µmoL/mL). The G. fisheri showed more potential for improving gut health than U. rigida. Particularly, PF-G induced butyric acid production comparable to that of inulin control (5.4 and 6.9 µmoL/mL) and the highest production when compared with other substrates (1.8–3.3 µmoL/mL). While SW-G stimulated the growth of beneficial bacteria, including Roseburia and Faecalibacterium. These findings further demonstrate that seaweeds and their derived polysaccharides have the potential to be used as dietary supplements with gut health benefits.
No takes yet. Share an insight, caveat, or question.
Charoensiddhi et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: